These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37020741)

  • 21. Optimal planning of the COVID-19 vaccine supply chain.
    Georgiadis GP; Georgiadis MC
    Vaccine; 2021 Aug; 39(37):5302-5312. PubMed ID: 34373118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drone routing problem model for last-mile delivery using the public transportation capacity as moving charging stations.
    Moadab A; Farajzadeh F; Fatahi Valilai O
    Sci Rep; 2022 Apr; 12(1):6361. PubMed ID: 35428789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
    Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
    BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust optimization model of anti-epidemic supply chain under technological innovation: learning from COVID-19.
    Song M; Yuan S; Bo H; Song J; Pan X; Jin K
    Ann Oper Res; 2022 Jul; ():1-31. PubMed ID: 35855699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustainable closed-loop supply chain network under uncertainty: a response to the COVID-19 pandemic.
    Rafigh P; Akbari AA; Bidhandi HM; Kashan AH
    Environ Sci Pollut Res Int; 2021 Sep; ():1-17. PubMed ID: 34519990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of Drones to Deliver Rift Valley Fever Vaccines in Rwanda: Perceptions and Recommendations.
    Griffith EF; Schurer JM; Mawindo B; Kwibuka R; Turibyarive T; Amuguni JH
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing a food supply chain strategy during COVID-19 pandemic using an integrated Agent-Based Modelling and Robust Optimization.
    Achmad ALH; Chaerani D; Perdana T
    Heliyon; 2021 Nov; 7(11):e08448. PubMed ID: 34841118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures.
    Matter D; Potgieter L
    PLoS One; 2021; 16(3):e0248053. PubMed ID: 33667263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scenarios for handling the impact of COVID-19 based on food supply network through regional food hubs under uncertainty.
    Perdana T; Chaerani D; Achmad ALH; Hermiatin FR
    Heliyon; 2020 Oct; 6(10):e05128. PubMed ID: 33020743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    Hernandez I; Dickson S; Tang S; Gabriel N; Berenbrok LA; Guo J
    PLoS Med; 2022 Jul; 19(7):e1004069. PubMed ID: 35901171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bi-objective robust optimization approach for the management of infectious wastes with demand uncertainty during a pandemic.
    Zhao J; Wu B; Ke GY
    J Clean Prod; 2021 Sep; 314():127922. PubMed ID: 34511740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
    PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination for pandemic influenza: a six point agenda for interpandemic years.
    Fedson DS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S74-7. PubMed ID: 14730273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical Industry's Engagement in the Global Equitable Distribution of COVID-19 Vaccines: Corporate Social Responsibility of EUL Vaccine Developers.
    Sung M; Huang Y; Duan Y; Liu F; Jin Y; Zheng Z
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syringes must be prioritized globally to ensure equitable access to COVID-19 and other essential vaccines and to sustain safe injection practices.
    Fritz J; Griffin E; Hammack R; Herrick T; Jarrahian C
    Hum Vaccin Immunother; 2022 Dec; 18(7):2077580. PubMed ID: 35648471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model.
    Patterson BJ; Herring WL; Van Oorschot D; Curran D; Carrico J; Zhang Y; Ackerson BK; Bruxvoort K; Sy LS; Tseng HF
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1567-1575. PubMed ID: 33043821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the impacts of COVID-19 outbreak on supply chain risks by modified failure mode and effects analysis: a case study in an automotive company.
    Ghadir AH; Vandchali HR; Fallah M; Tirkolaee EB
    Ann Oper Res; 2022 Mar; ():1-31. PubMed ID: 35378835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 5-year look-back at the notification and management of vaccine supply shortages in Germany.
    Miranda-García MA; Hoffelner M; Stoll H; Ruhaltinger D; Cichutek K; Siedler A; Bekeredjian-Ding I
    Euro Surveill; 2022 Apr; 27(17):. PubMed ID: 35485267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The global COVID-19 vaccine surplus: tackling expiring stockpiles.
    Quan NK; Anh NLM; Taylor-Robinson AW
    Infect Dis Poverty; 2023 Mar; 12(1):21. PubMed ID: 36941709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling a sustainable vaccine supply chain for a healthcare system.
    Chowdhury NR; Ahmed M; Mahmud P; Paul SK; Liza SA
    J Clean Prod; 2022 Oct; 370():133423. PubMed ID: 35975192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.